# $BCHAT Social Sentiment & Intelligence — 2026-09-03 09:50 UTC > **Asset:** $BCHAT > **Momentum Status:** Cooling Down > **Timestamp:** 2026-09-03 09:50 UTC (2026-09-03T09:50:00Z) > **Canonical URL:** https://cryptitalk.com/2026-09-03-09-50/crypto/BCHAT > **Overview Brief:** https://cryptitalk.com/2026-09-03-09-50/crypto.md --- ## 10-Minute Social Metrics - **Posts Analyzed:** 1 - **Total Impressions:** 2 - **Likes:** 0 - **Retweets:** 0 - **Comments:** 0 --- ## Momentum & Sentiment Analysis Total Engagement - Comments: 0, Retweets: 0, Likes: 0, Impressions: 2 --- ## Cited Community Posts & Evidence ### Post #1 by @BioProtocol > **Author:** [@BioProtocol](https://x.com/BioProtocol) > **Metrics:** 1 likes · 0 retweets · 0 comments · 1.6K views > **Source Link:** [https://x.com/BioProtocol/status/2095450732225036371](https://x.com/BioProtocol/status/2095450732225036371) > **Visual Context:** A 'FEATURED STORY' graphic highlighting how 'ARPA-H's PROSPR program' is solving a longevity field bottleneck, featuring a New York Times article titled 'The Most Important Longevity Term You've Probably Never Heard of' about intrinsic capacity as a way to measure human aging. > > "Proving that a treatment extends human life can take decades. That timeline shapes which longevity research gets funded. @ARPA_H ’s PROSPR program is testing whether changes in intrinsic capacity can help measure treatment benefits within a few years. This includes mobility," --- ## Contributing Accounts - `@sonsakripto` (https://x.com/sonsakripto)